UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

Gastroenterology (New York, N.Y. 1943), 2016-07, Vol.151 (1), p.110-119

2016

Volltextzugriff (PDF)

Food-related advertising on preschool television: building brand recognition in young viewers

Pediatrics (Evanston), 2006-10, Vol.118 (4), p.1478-1485

Connor, Susan M

2006

Volltextzugriff (PDF)

The Evolving Role of Technology in Delivering Patient-centric, Empowered Health Care in Inflammatory Bowel Disease: Patient Experience Using Crohn’s Colitis Care e-Health Consumer Platform

Inflammatory bowel diseases, 2023-09, Vol.29 (9), p.1510-1511

2023

Volltextzugriff (PDF)

Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial

The Lancet (British edition), 2017-03, Vol.389 (10075), p.1218-1228

2017

Volltextzugriff (PDF)

Effectiveness of Interventions for Caregivers of People With Alzheimer's Disease and Related Major Neurocognitive Disorders: A Systematic Review

The American journal of occupational therapy, 2017-09, Vol.71 (5), p.7105180020p1-7105180020p10

2017

Volltextzugriff (PDF)

Anemia and iron deficiency in gastrointestinal and liver conditions

World journal of gastroenterology : WJG, 2016-09, Vol.22 (35), p.7908-7925

2016

Volltextzugriff (PDF)

Is the European Crohn's and Colitis organisation (ECCO) e-guide an acceptable and feasible tool for increasing gastroenterologists' guideline adherence? A mixed methods evaluation

BMC medical education, 2024-05, Vol.24 (1), p.529-10, Article 529

2024

Volltextzugriff (PDF)

Biologic Therapeutic Drug Monitoring in Australia

Journal of gastroenterology and hepatology, 2016-06, Vol.31 (S1), p.8-9

J Connor, Susan

2016

Volltextzugriff (PDF)

When and why health care personnel respond to a disaster: the state of the science

Prehospital and disaster medicine, 2014-06, Vol.29 (3), p.270-274

Connor, Susan B

2014

Volltextzugriff (PDF)

Dietary Emulsifier Exposure in People With Inflammatory Bowel Disease Compared With Healthy Controls: Is There a Cause for Concern?

Inflammatory bowel diseases, 2024-08, Vol.30 (8), p.1241-1250

2024

Volltextzugriff (PDF)

Metabolic profiling detects biomarkers of protein degradation in COPD patients

The European respiratory journal, 2012-08, Vol.40 (2), p.345-355

2012

Volltextzugriff (PDF)

Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes

Molecular bioSystems, 2010-05, Vol.6 (5), p.99-921

2010

Volltextzugriff (PDF)

S1200 Characterization of Hospitalized Patients With Ulcerative Colitis Treated With Tofacitinib in the OCTAVE Clinical Program for up to 7.8 Years

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S915-S916

2023

Volltextzugriff (PDF)

Integration of mental health and quality of life screening tools in an inflammatory bowel disease‐specific electronic medical record (Crohn Colitis Care): process and early outcomes

Internal medicine journal, 2023-01, Vol.53 (1), p.136-139

2023

Volltextzugriff (PDF)

The effect of a nurse-led advice line and virtual clinic on inflammatory bowel disease service delivery: an Australian study

European journal of gastroenterology & hepatology, 2021-12, Vol.33 (1S Suppl 1), p.e771-e776

2021

Volltextzugriff (PDF)

Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic Review

Pathogens (Basel), 2023-02, Vol.12 (2), p.262

2023

Volltextzugriff (PDF)

Clinician Adherence to Inflammatory Bowel Disease Guidelines: Results of a Qualitative Study of Barriers and Enablers

Crohn's & colitis 360, 2023-07, Vol.5 (3), p.otac018-otac018

2023

Volltextzugriff (PDF)

Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial

Clinical gastroenterology and hepatology, 2024-05

2024

Volltextzugriff (PDF)

Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn’s Perianal Fistulas

Clinical gastroenterology and hepatology, 2022-06, Vol.20 (6), p.1306-1314

2022

Volltextzugriff (PDF)

Disability and Teaching

1, 2014

Volltextzugriff (PDF)

Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse

Gastrointestinal endoscopy, 2017-12, Vol.86 (6), p.1070-1078

2017

Volltextzugriff (PDF)

Health Communication Research Informs Inflammatory Bowel Disease Practice and Research: A Narrative Review

Crohn's & colitis 360, 2023-07, Vol.5 (3), p.otad021-otad021

2023

Volltextzugriff (PDF)

Factors associated with the intention of health care personnel to respond to a disaster

Prehospital and disaster medicine, 2014-12, Vol.29 (6), p.555-560

Connor, Susan B

2014

Volltextzugriff (PDF)

Safety, satisfaction and cost savings of accelerated infusions of standard and intensified‐dose infliximab for inflammatory bowel disease

Internal medicine journal, 2022-12, Vol.52 (12), p.2143-2149

2022

Volltextzugriff (PDF)

1 – 25 von 965

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(817)
Mit Volltextzugriff
(775)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(964)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

Food-related advertising on preschool television: building brand recognition in young viewers

The Evolving Role of Technology in Delivering Patient-centric, Empowered Health Care in Inflammatory Bowel Disease: Patient Experience Using Crohn’s Colitis Care e-Health Consumer Platform

Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial

Effectiveness of Interventions for Caregivers of People With Alzheimer's Disease and Related Major Neurocognitive Disorders: A Systematic Review

Anemia and iron deficiency in gastrointestinal and liver conditions

Is the European Crohn's and Colitis organisation (ECCO) e-guide an acceptable and feasible tool for increasing gastroenterologists' guideline adherence? A mixed methods evaluation

Biologic Therapeutic Drug Monitoring in Australia

When and why health care personnel respond to a disaster: the state of the science

Dietary Emulsifier Exposure in People With Inflammatory Bowel Disease Compared With Healthy Controls: Is There a Cause for Concern?

Metabolic profiling detects biomarkers of protein degradation in COPD patients

Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes

S1200 Characterization of Hospitalized Patients With Ulcerative Colitis Treated With Tofacitinib in the OCTAVE Clinical Program for up to 7.8 Years

Integration of mental health and quality of life screening tools in an inflammatory bowel disease‐specific electronic medical record (Crohn Colitis Care): process and early outcomes

The effect of a nurse-led advice line and virtual clinic on inflammatory bowel disease service delivery: an Australian study

Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic Review

Clinician Adherence to Inflammatory Bowel Disease Guidelines: Results of a Qualitative Study of Barriers and Enablers

Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial

Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn’s Perianal Fistulas

Disability and Teaching

Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse

Health Communication Research Informs Inflammatory Bowel Disease Practice and Research: A Narrative Review

Factors associated with the intention of health care personnel to respond to a disaster

Safety, satisfaction and cost savings of accelerated infusions of standard and intensified‐dose infliximab for inflammatory bowel disease

Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial

Suchergebnisse filtern